Person:
Bhere, Deepak

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Bhere

First Name

Deepak

Name

Bhere, Deepak

Filters

20141

Settings

Author's Publications: search.filters.isAuthorOfPublication.b3227fd4-d362-40a9-8aa4-7d44c960efd1

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
    (American Association for Cancer Research (AACR), 2014) Sullivan, James; Nahed, Brian; Madden, M. W.; Oliveira, S. M.; Springer, S.; Bhere, Deepak; Chi, A. S.; Wakimoto, Hiroaki; Rothenberg, S. M.; Sequist, Lecia; Kapur, R.; Shah, Khalid; Iafrate, Anthony; Curry, William; Loeffler, Jay; Batchelor, Tracy; Louis, David; Toner, Mehmet; Maheswaran, Shyamala; Haber, Daniel
    Glioblastoma (GBM) is a highly aggressive brain cancer characterized by local invasion and angiogenic recruitment, yet metastatic dissemination is extremely rare. Here, we adapted a microfluidic device to deplete hematopoietic cells from blood specimens of patients with GBM, uncovering evidence of circulating brain tumor cells (CTCs). Staining and scoring criteria for GBM CTCs were first established using orthotopic patient-derived xenografts (PDX), and then applied clinically: CTCs were identified in at least one blood specimen from 13/33 patients (39%; 26/87 samples). Single GBM CTCs isolated from both patients and mouse PDX models demonstrated enrichment for mesenchymal over neural differentiation markers, compared with primary GBMs. Within primary GBMs, RNA-in-situ hybridization identifies a subpopulation of highly migratory mesenchymal tumor cells, and in a rare patient with disseminated GBM, systemic lesions were exclusively mesenchymal. Thus, a mesenchymal subset of GBM cells invades into the vasculature, and may proliferate outside the brain.